Svetlana Lucas

Insider Reports History

Location
San Diego, CA
Signature
/s/ Herb Cross, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Svetlana Lucas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jasper Therapeutics, Inc. Director Voting Common Stock 20,000 $48,600 $2.43 22 Sep 2025 Direct
aTYR PHARMA INC Director Stock Option (right to buy) 50,000 01 May 2025 Direct
Jasper Therapeutics, Inc. Director Common Stock Warrant (right to buy) 20,000 22 Sep 2025 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 7,500 03 Jul 2025 Direct

Insider Reports Filed by Svetlana Lucas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JSPR Jasper Therapeutics, Inc. 22 Sep 2025 2 +$48,600 4 Director 24 Sep 2025, 16:01
JSPR Jasper Therapeutics, Inc. 03 Jul 2025 1 $0 4 Director 03 Jul 2025, 16:20
ATYR aTYR PHARMA INC 01 May 2025 1 $0 4 Director 02 May 2025, 17:22
JSPR Jasper Therapeutics, Inc. 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 06:07
JSPR Jasper Therapeutics, Inc. 18 Jun 2024 0 $0 3 Director 20 Jun 2024, 06:05
ATYR aTYR PHARMA INC 22 May 2024 1 $0 4 Director 23 May 2024, 19:19
ATYR aTYR PHARMA INC 17 May 2023 1 $0 4 Director 19 May 2023, 16:30
ATYR aTYR PHARMA INC 26 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:53
ATYR aTYR PHARMA INC 26 Apr 2022 1 $0 4 Director 28 Apr 2022, 19:50